Caption Management »

Acelyrin shares owned by Caption Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Caption Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.1M 1.2M 6.75
2023-09-30 $2.2M 218k 10.17

More positions owned by Caption Management

First Solar Call Option (FSLR)
Alnylam Pharmaceuticals Call Option (ALNY)
Citigroup Com New Call Option (C)
Verizon Communications Put Option (VZ)
Caterpillar Call Option (CAT)
Insmed Com Par $.01 Call Option (INSM)
Snowflake Cl A Call Option (SNOW)
Capri Holdings SHS Call Option (CPRI)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Sarepta Therapeutics Call Option (SRPT)
United States Steel Corporation Call Option (X)
AmerisourceBergen Call Option (COR)
Alphabet Cap Stk Cl C Put Option (GOOG)
Adobe Systems Incorporated Put Option (ADBE)
Celestica Call Option (CLS)

View all positions for Caption Management

Top funds holding Acelyrin

AyurMaya Capital Management Company
Citadel Advisors
FMR
BlackRock
Vanguard Group
Millennium Management
OrbiMed Advisors
venBio Partners
T. Rowe Price Investment Management
Adage Capital Partners GP
Blue Owl Capital Holdings
Tybourne Capital Management
General Atlantic
Jpmorgan Chase & Co
Samsara BioCapital

View all funds holding Acelyrin